U.S.
Biohaven Ltd. up 25%: the FDA agreed to review, not approve
On Oct. 22, Biohaven Ltd. (+25%) had an FDA review-acceptance 8-K and Pool Corporation (+14%) had an earnings 8-K, while no reason was found for Concentrix Corporation (+14%).
FDA review stocks in Korea: why they moved
1 article(s) on Korean FDA review stocks, checked against filings and numbers.